• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Press release

Analyst Group: Analyst Group Comment on NMD’s Decision to Bring Forward the Launch of Nozoil and Place an Additional Order

Nosa Plugs

Nosa Plugs AB (”Nosa Plugs” or ”the Company”) announced on 28 May 2026 that Norwegian pharmaceutical wholesaler Norsk Medisinaldepot (”NMD”), which recently added Nozoil to its portfolio for distribution on the Norwegian pharmacy market, is bringing forward its pharmacy launch to 1 June. In connection with the launch, NMD has placed an additional order of SEK 160 TSEK, bringing the combined value of both orders to approximately SEK 400 TSEK. The reason for the accelerated timeline is that Vitus apotek and Ditt apotek are already seeing strong demand for Nozoil and are beginning to sell the product in stores and online as of today, Thursday 28 May. Vitus apotek and Ditt apotek together comprise approximately 550 pharmacies, covering a majority of Norwegian pharmacies. Nozoil is also available through Apotera.


Read Analyst Group’s comment here


About Analyst Group: One of Sweden's leading equity research boutiques with focus on small and medium-sized listed companies.
Read more about Analyst Group
 
This is a press release from Analyst Group regarding the publication of a comment on Nosa Plugs. Readers may assume that Analyst Group has received compensation for making the comment. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.